MassVentures Welcomes Jason Allen

Jason Allen Joins MassVentures as Vice President

 

MassVentures is pleased to announce that Jason Allen has joined MassVentures as a Vice President.  In this role, Allen will source and execute new investment opportunities, manage investments in portfolio companies, and engage with the Massachusetts entrepreneurial and innovation community.

“We are delighted that Jason Allen is joining the team as a Vice President,” said MassVentures President Jerry Bird.  “His background in venture capital as well as in sales, marketing and business operations at emerging technology companies will enhance our capabilities as we continue our investments in the Commonwealth’s innovation economy.”

Allen comes to MassVentures from Ovia Insights, a division of Ovia Health, where he led sales and marketing efforts.  Simultaneously he worked at Launch Capital, where he focused on sourcing and evaluating new investments across industry verticals. He is an experienced operator in SaaS, B2B enterprise software, and marketplace companies. He has also worked as the Director of Inside Sales at Attivio–a natural language processing, AI powered search and text company.  Allen earned a J.D. from Northeastern University School of Law, a Master of Theological Studies from Harvard Divinity School and a B.A. from Denison University.

“I am humbled to join such a talented team of investors at MassVentures,” said Jason Allen. “Thank you to the MassVentures Board of Directors, Jerry Bird, and Charlie Hipwood for their support. I look forward to using my skills to help the MassVentures team fund, promote, and grow the most innovative companies here in Massachusetts.”

MassVenturesis a quasi-public venture capital firm focused on fueling the Commonwealth’s innovation economy by funding early-stage, high-growth Massachusetts startups as they move from concept to commercialization. MassVentures also awards funding through its award winning START (SBIR Targeted Technologies) program, which helps growing Massachusetts-based companies commercialize technologies developed under SBIR and STTR contracts.